(1)
Efficacy of Novel Multimodality Pigment-Correcting Serum for Moderate to Severe Facial Hyperpigmentation, Including Melasma, in a 12-Week, Split-Face, Double-Blind, Randomized Controlled Trial. J of Skin 2023, 7 (2), s190. https://doi.org/10.25251/skin.7.supp.190.